Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers

References

• MedzhitovRPreston-HurlburtPJanewayCAA human homologue of the Drosophila Toll protein signals activation of adaptive immunityNature199738866403943979237759
   PubMed Web of Science ®Google Scholar
• JinMSLeeJOStructures of the toll-like receptor family and its ligand complexesImmunity200829218219118701082
   PubMed Web of Science ®Google Scholar
• O’NeillLABowieAGThe family of five: TIR-domain- containing adaptors in Toll-like receptor signallingNat Rev Immunol20077535336417457343
   PubMed Web of Science ®Google Scholar
• ParkBSSongDHKimHMChoiBSLeeHLeeJOThe structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complexNature200945872421191119519252480
   PubMed Web of Science ®Google Scholar
• OpalSMEsmonCTBench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsisCrit Care200371233812617738
   PubMed Web of Science ®Google Scholar
• IkebeMKitauraYNakamuraMLipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathwayJ Surg Oncol2009100872573119722233
   PubMed Web of Science ®Google Scholar
• Del PozoJLPrimers on molecular pathways: lipopolysaccharide signaling – potential role in pancreatitis and pancreatic cancerPancreatology2010102–311411820460943
   PubMed Web of Science ®Google Scholar
• NagaiYAkashiSNagafukuMEssential role of MD-2 in LPS responsiveness and TLR4 distributionNat Immunol20023766767212055629
   PubMed Web of Science ®Google Scholar
• GioanniniTLTeghanemtAZhangDIsolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrationsProc Natl Acad Sci U S A2004101124186419115010525
   PubMed Web of Science ®Google Scholar
• OhtoUFukaseKMiyakeKSatowYCrystal structures of human MD-2 and its complex with antiendotoxic lipid IVaScience200731658311632163417569869
   PubMed Web of Science ®Google Scholar
• LoiarroMRuggieroVSetteCTargeting TLR/IL-1R signalling in human diseasesMediators Inflamm2010201067436320396389
   PubMed Web of Science ®Google Scholar
• SatoYGotoYNaritaNHoonDSCancer Cells Expressing Toll-like Receptors and the Tumor MicroenvironmentCancer Microenviron20092 Suppl 120521419685283
   PubMedGoogle Scholar
• Pimentel-NunesPSoaresJBRoncon-AlbuquerqueRDinis-RibeiroMLeite-MoreiraAFToll-like receptors as therapeutic targets in gastrointestinal diseasesExpert Opin Ther Targets201014434736820146632
   PubMed Web of Science ®Google Scholar
• OtteJMCarioEPodolskyDKMechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cellsGastroenterology200412641054107015057745
   PubMed Web of Science ®Google Scholar
• MansellASmithRDoyleSLSuppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradationNat Immunol20067214815516415872
   PubMed Web of Science ®Google Scholar
• Pimentel-NunesPGonçalvesNBoal-CarvalhoIHelicobacter pylori induces increased expression of Toll-like receptors and decreased Toll-interacting protein in gastric mucosa that persists throughout gastric carcinogenesisHelicobacter2013181223223061653
   PubMed Web of Science ®Google Scholar
• TsanMFToll-like receptors, inflammation and cancerSemin Cancer Biol2006161323716153858
   PubMed Web of Science ®Google Scholar
• KimbrellDABeutlerBThe evolution and genetics of innate immunityNat Rev Genet20012425626711283698
   PubMed Web of Science ®Google Scholar
• KawaiTAkiraSThe role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsNat Immunol201011537338420404851
   PubMed Web of Science ®Google Scholar
• LuYCYehWCOhashiPSLPS/TLR4 signal transduction pathwayCytokine200842214515118304834
   PubMed Web of Science ®Google Scholar
• UnderhillDMToll-like receptors: networking for successEur J Immunol20033371767177512811836
   PubMed Web of Science ®Google Scholar
• SoEYOuchiTThe application of Toll like receptors for cancer therapyInt J Biol Sci20106767568121060729
   PubMed Web of Science ®Google Scholar
• FrenchSWOlivaJFrenchBALiJBardag-GorceFAlcohol, nutrition and liver cancer: role of Toll-like receptor signalingWorld J Gastroenterol201016111344134820238401
   PubMed Web of Science ®Google Scholar
• Rakoff-NahoumSMedzhitovRToll-like receptors and cancerNat Rev Cancer200991576319052556
   PubMed Web of Science ®Google Scholar
• HuangBZhaoJUnkelessJCFengZHXiongHTLR signaling by tumor and immune cells: a double-edged swordOncogene200827221822418176603
   PubMed Web of Science ®Google Scholar
• MiyakeKRoles for accessory molecules in microbial recognition by Toll-like receptorsJ Endotoxin Res200612419520416953972
   PubMedGoogle Scholar
• MillerSIErnstRKBaderMWLPS, TLR4 and infectious disease diversityNat Rev Microbiol200531364615608698
   PubMed Web of Science ®Google Scholar
• OblakAJeralaRToll-like receptor 4 activation in cancer progression and therapyClin Dev Immunol2011201160957922110526
   PubMedGoogle Scholar
• ParkSHKimNDJungJKLeeCKHanSBKimYMyeloid differentiation 2 as a therapeutic target of inflammatory disordersPharmacol Ther2012133329129822119168
   PubMed Web of Science ®Google Scholar
• AkiraSUematsuSTakeuchiOPathogen recognition and innate immunityCell2006124478380116497588
   PubMed Web of Science ®Google Scholar
• FukataMAbreuMTRole of Toll-like receptors in gastrointestinal malignanciesOncogene200827223424318176605
   PubMed Web of Science ®Google Scholar
• GotoYArigamiTKitagoMActivation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factorsMol Cancer Ther20087113642365319001446
   PubMed Web of Science ®Google Scholar
• HeWLiuQWangLChenWLiNCaoXTLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistanceMol Immunol200744112850285917328955
   PubMed Web of Science ®Google Scholar
• KellyMGAlveroABChenRTLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancerCancer Res20066673859386816585214
   PubMed Web of Science ®Google Scholar
• LiHHanYGuoQZhangMCaoXCancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1J Immunol2009182124024919109155
   PubMed Web of Science ®Google Scholar
• StraussLBergmannCWhitesideTLHuman circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosisJ Immunol200918231469148019155494
   PubMed Web of Science ®Google Scholar
• FukataMChenAVamadevanASToll-like receptor-4 promotes the development of colitis-associated colorectal tumorsGastroenterology200713361869188118054559
   PubMed Web of Science ®Google Scholar
• UronisJMMühlbauerMHerfarthHHRubinasTCJonesGSJobinCModulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibilityPLoS One200946e602619551144
   PubMed Web of Science ®Google Scholar
• SwannJBVeselyMDSilvaADemonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesisProc Natl Acad Sci U S A2008105265265618178624
   PubMed Web of Science ®Google Scholar
• NauglerWESakuraiTKimSGender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 productionScience2007317583412112417615358
   PubMed Web of Science ®Google Scholar
• Rakoff-NahoumSMedzhitovRRegulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88Science2007317583412412717615359
   PubMed Web of Science ®Google Scholar
• KilleenSDWangJHAndrewsEJRedmondHPBacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-kappaB-dependent activation of the urokinase plasminogen activator systemBr J Cancer2009100101589160219436306
   PubMed Web of Science ®Google Scholar
• HuangBZhaoJLiHToll-like receptors on tumor cells facilitate evasion of immune surveillanceCancer Res200565125009501415958541
   PubMed Web of Science ®Google Scholar
• DanHCSunMKanekoSAkt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP)J Biol Chem200427975405541214645242
   PubMed Web of Science ®Google Scholar
• AkiraSTakedaKToll-like receptor signallingNat Rev Immunol20044749951115229469
   PubMed Web of Science ®Google Scholar
• FukataMAbreuMTPathogen recognition receptors, cancer and inflammation in the gutCurr Opin Pharmacol20099668068719828376
   PubMed Web of Science ®Google Scholar
• LotzeMTZehHJRubartelliAThe grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunityImmunol Rev2007220608117979840
   PubMed Web of Science ®Google Scholar
• EllermanJEBrownCKde VeraMMasquerader: high mobility group box-1 and cancerClin Cancer Res200713102836284817504981
   PubMed Web of Science ®Google Scholar
• BrezniceanuMLVölpKBösserSHMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinomaFASEB J200317101295129712759333
   PubMed Web of Science ®Google Scholar
• PoserIGolobMBuettnerRBosserhoffAKUpregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotypeMol Cell Biol20032382991299812665595
   PubMed Web of Science ®Google Scholar
• SasahiraTKiritaTOueNHigh mobility group box-1-inducible melanoma inhibitory activity is associated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinomaCancer Sci20089991806181218616526
   PubMed Web of Science ®Google Scholar
• SchlueterCWeberHMeyerBAngiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch moleculeAm J Pathol200516641259126315793304
   PubMed Web of Science ®Google Scholar
• van BeijnumJRPetersenKGriffioenAWTumor endothelium is characterized by a matrix remodeling signatureFront Biosci (Schol Ed)2009121622519482697
   PubMedGoogle Scholar
• SimsGPRoweDCRietdijkSTHerbstRCoyleAJHMGB1 and RAGE in inflammation and cancerAnnu Rev Immunol20102836738820192808
   PubMed Web of Science ®Google Scholar
• HiratsukaSIshibashiSTomitaTPrimary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability fociNat Commun20134185323673638
   PubMed Web of Science ®Google Scholar
• HiratsukaSWatanabeASakuraiYThe S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phaseNat Cell Biol200810111349135518820689
   PubMed Web of Science ®Google Scholar
• MantovaniAAllavenaPSicaABalkwillFCancer-related inflammationNature2008454720343644418650914
   PubMed Web of Science ®Google Scholar
• CandidoJHagemannTCancer-related inflammationJ Clin Immunol201333 Suppl 1S79S8423225204
   PubMed Web of Science ®Google Scholar
• PerroneGRuffiniPACatalanoVIntratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancerEur J Cancer200844131875188218617393
   PubMed Web of Science ®Google Scholar
• MartinezFOSicaAMantovaniALocatiMMacrophage activation and polarizationFront Biosci20081345346117981560
   PubMed Web of Science ®Google Scholar
• ZouWImmunosuppressive networks in the tumour environment and their therapeutic relevanceNat Rev Cancer20055426327415776005
   PubMed Web of Science ®Google Scholar
• ZhouYHLiaoSJLiDTLR4 ligand/H2O2 enhances TGF-β1 signaling to induce metastatic potential of non-invasive breast cancer cells by activating non-Smad pathwaysPLoS One201385e6590623734265
   PubMed Web of Science ®Google Scholar
• SekiEDe MinicisSOsterreicherCHTLR4 enhances TGF-beta signaling and hepatic fibrosisNat Med200713111324133217952090
   PubMed Web of Science ®Google Scholar
• BhowmickNAChytilAPliethDTGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epitheliaScience2004303565984885114764882
   PubMed Web of Science ®Google Scholar
• AzumaISeyaTDevelopment of immunoadjuvants for immunotherapy of cancerInt Immunopharmacol2001171249125911460306
   PubMed Web of Science ®Google Scholar
• OkamotoMFuruichiSNishiokaYExpression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparationCancer Res200464155461547015289356
   PubMed Web of Science ®Google Scholar
• OkamotoMSatoMToll-like receptor signaling in anti-cancer immunityJ Med Invest2003501–292412630564
   PubMedGoogle Scholar
• LinYSHuangLDLinCHIn vitro and in vivo anticancer activity of a synthetic glycolipid as Toll-like receptor 4 (TLR4) activatorJ Biol Chem201128651437824379221949133
   PubMed Web of Science ®Google Scholar
• GrondinVSeksikPDumontSRegulation of colon cancer cell proliferation and migration by MD-2 activityInnate Immun201117441442220699280
   PubMed Web of Science ®Google Scholar
• DeguchiATomitaTOmoriTSerum Amyloid A3 Binds MD-2 To Activate p38 and NF-κB Pathways in a MyD88-Dependent MannerJ Immunol201319141856186423858030
   PubMed Web of Science ®Google Scholar
• HartmannEWollenbergBRothenfusserSIdentification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancerCancer Res200363196478648714559840
   PubMed Web of Science ®Google Scholar
• SzczepańskiMStelmachowskaMStryczyńskiLAssessment of expression of toll-like receptors 2, 3 and 4 in laryngeal carcinomaEur Arch Otorhinolaryngol2007264552553017165086
   PubMed Web of Science ®Google Scholar
• SzczepanskiMJCzystowskaMSzajnikMTriggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attackCancer Res20096973105311319318560
   PubMed Web of Science ®Google Scholar
• StarskaKFormaELewy-TrendaIThe expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinomaFolia Histochem Cytobiol200947340141020164024
   PubMed Web of Science ®Google Scholar
• StarskaKFormaEBryśMThe expression of TLR pathway molecules in peripheral blood mononuclear cells and their relationship with tumor invasion and cytokine secretion in laryngeal carcinomaAdv Med Sci201257112413522240197
   PubMed Web of Science ®Google Scholar
• YaoHRahmanICurrent concepts on the role of inflammation in COPD and lung cancerCurr Opin Pharmacol20099437538319615942
   PubMed Web of Science ®Google Scholar
• BauerAKDixonDDeGraffLMToll-like receptor 4 in butylated hydroxytoluene-induced mouse pulmonary inflammation and tumorigenesisJ Natl Cancer Inst200597231778178116333033
   PubMedGoogle Scholar
• BauerAKFostelJDegraffLMTranscriptomic analysis of pathways regulated by toll-like receptor 4 in a murine model of chronic pulmonary inflammation and carcinogenesisMol Cancer2009810719925653
   PubMed Web of Science ®Google Scholar
• MacRedmondREGreeneCMDorscheidDRMcElvaneyNGO’NeillSJEpithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smokeRespir Res200788418034897
   PubMed Web of Science ®Google Scholar
• ZhangYBHeFLFangMIncreased expression of Toll-like receptors 4 and 9 in human lung cancerMol Biol Rep20093661475148118763053
   PubMed Web of Science ®Google Scholar
• ManegoldCGravenorDWoytowitzDRandomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancerJ Clin Oncol200826243979398618711188
   PubMed Web of Science ®Google Scholar
• RenTWenZKLiuZMTargeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patientsCancer Invest200826544845518568766
   PubMed Web of Science ®Google Scholar
• WangHRayburnERWangWKandimallaERAgrawalSZhangRChemotherapy and chemosensitization of non-small cell lung cancer with a novel immunomodulatory oligonucleotide targeting Toll-like receptor 9Mol Cancer Ther2006561585159216818518
   PubMed Web of Science ®Google Scholar
• DroemannDAlbrechtDGerdesJHuman lung cancer cells express functionally active Toll-like receptor 9Respir Res20056115631627
   PubMed Web of Science ®Google Scholar
• ParkinDMPisaniPFerlayJGlobal cancer statisticsCA Cancer J Clin19994913364 110200776
   PubMed Web of Science ®Google Scholar
• McCullochPWardJTekkisPPASCOT group of surgeons; British Oesophago-Gastric Cancer GroupMortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort studyBMJ200332774251192119714630753
   PubMed Web of Science ®Google Scholar
• ChattopadhyayISinghAPhukanRGenome-wide analysis of chromosomal alterations in patients with esophageal squamous cell carcinoma exposed to tobacco and betel quid from high-risk area in IndiaMutat Res2010696213013820083228
   PubMed Web of Science ®Google Scholar
• SheyhidinINabiGHasimAOverexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinomaWorld J Gastroenterol201117323745375121990957
   PubMed Web of Science ®Google Scholar
• KawaharaTKuwanoYTeshima-KondoSToll-like receptor 4 regulates gastric pit cell responses to Helicobacter pylori infectionJ Med Invest2001483–419019711694959
   PubMedGoogle Scholar
• IshiharaSRumiMAKadowakiYEssential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritisJ Immunol200417321406141615240737
   PubMed Web of Science ®Google Scholar
• ChochiKIchikuraTKinoshitaMHelicobacter pylori augments growth of gastric cancers via the lipopolysaccharide-toll-like receptor 4 pathway whereas its lipopolysaccharide attenuates antitumor activities of human mononuclear cellsClin Cancer Res200814102909291718483357
   PubMed Web of Science ®Google Scholar
• SchmausserBAndrulisMEndrichSMüller-HermelinkHKEckMToll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pyloriInt J Med Microbiol2005295317918516044857
   PubMed Web of Science ®Google Scholar
• KawauchiKYagihashiATsujiNHuman beta-defensin-3 induction in H. pylori-infected gastric mucosal tissuesWorld J Gastroenterol200612365793579717007044
   PubMed Web of Science ®Google Scholar
• FukataMChenAKlepperACox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestineGastroenterology2006131386287716952555
   PubMed Web of Science ®Google Scholar
• OharaTMorishitaTSuzukiHHibiTHeterozygous Thr 135 Ala polymorphism at leucine-rich repeat (LRR) in genomic DNA of toll-like receptor 4 in patients with poorly-differentiated gastric adenocarcinomasInt J Mol Med2006181596316786156
   PubMed Web of Science ®Google Scholar
• HoldGLRabkinCSChowWHA functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursorsGastroenterology2007132390591217324405
   PubMed Web of Science ®Google Scholar
• SantiniDAngelettiSRuzzoAToll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypesClin Exp Immunol2008154336036418826495
   PubMed Web of Science ®Google Scholar
• Trejo-de laOATorresJPérez-RodríguezMTLR4 single-nucleotide polymorphisms alter mucosal cytokine and chemokine patterns in Mexican patients with Helicobacter pylori-associated gastroduodenal diseasesClin Immunol2008129233334018755634
   PubMed Web of Science ®Google Scholar
• RigoliLDi BellaCFedeleFTLR4 and NOD2/CARD15 genetic polymorphisms and their possible role in gastric carcinogenesisAnticancer Res201030251351720332463
   PubMed Web of Science ®Google Scholar
• Garza-GonzalezEBosques-PadillaFJMendoza-IbarraSIFlores-GutierrezJPMaldonado-GarzaHJPerez-PerezGIAssessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8 -251 polymorphisms in the risk for the development of distal gastric cancerBMC Cancer200777017462092
   PubMed Web of Science ®Google Scholar
• FukataMAbreuMTTLR4 signalling in the intestine in health and diseaseBiochem Soc Trans200735Pt 61473147818031248
   PubMed Web of Science ®Google Scholar
• CarioEPodolskyDKDifferential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel diseaseInfect Immun200068127010701711083826
   PubMed Web of Science ®Google Scholar
• AbreuMTFukataMArditiMTLR signaling in the gut in health and diseaseJ Immunol200517484453446015814663
   PubMed Web of Science ®Google Scholar
• HausmannMKiesslingSMestermannSToll-like receptors 2 and 4 are up-regulated during intestinal inflammationGastroenterology200212271987200012055604
   PubMed Web of Science ®Google Scholar
• CammarotaRBertoliniVPennesiGThe tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic markerJ Transl Med2010811221059221
   PubMed Web of Science ®Google Scholar
• FurrieEMacfarlaneSThomsonGMacfarlaneGTMicrobiology and Gut Biology GroupTayside Tissue and Tumour BankToll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteriaImmunology2005115456557416011525
   PubMed Web of Science ®Google Scholar
• RigoliLRomanoCCarusoRAClinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel diseaseWorld J Gastroenterol200814284454446118680223
   PubMed Web of Science ®Google Scholar
• HongJLeungEFraserAGMerrimanTRVishnuPKrissansenGWTLR2, TLR4 and TLR9 polymorphisms and Crohn’s disease in a New Zealand Caucasian cohortJ Gastroenterol Hepatol200722111760176617914947
   PubMed Web of Science ®Google Scholar
• BaumgartDCBuningCGeerdtsLThe c.1–260C.T promoter variant of CD14 but not the c.896A.G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel diseaseDigestion2007763–419620218174680
   PubMed Web of Science ®Google Scholar
• FranchimontDVermeireSEl HousniHDeficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299 gly polymorphism is associated with Crohn’s disease and ulcerative colitisGut200453798799215194649
   PubMed Web of Science ®Google Scholar
• BrandSStaudingerTSchnitzlerFThe role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn’s diseaseInflamm Bowel Dis200511764565215973118
   PubMed Web of Science ®Google Scholar
• GazouliMMantzarisGKotsinasAAssociation between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek populationWorld J Gastroenterol200511568168515655821
   PubMed Web of Science ®Google Scholar
• TörökHPGlasJTonenchiLMussackTFolwacznyCPolymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitisClin Immunol20041121859115207785
   PubMed Web of Science ®Google Scholar
• OostenbrugLEDrenthJPde JongDJAssociation between Toll-like receptor 4 and inflammatory bowel diseaseInflamm Bowel Dis200511656757515905704
   PubMed Web of Science ®Google Scholar
• OuburgSMallant-HentRCrusiusJBThe toll-like receptor 4 (TLR4) Asp299Gly polymorphism is associated with colonic localisation of Crohn’s disease without a major role for the Saccharomyces cerevisiae mannan-LBP-CD14-TLR4 pathwayGut200554343944015710998
   PubMed Web of Science ®Google Scholar
• ShenXShiRZhangHLiKZhaoYZhangRThe Toll-like receptor 4 D299G and T399I polymorphisms are associated with Crohn’s disease and ulcerative colitis: a meta-analysisDigestion2010812697720093834
   PubMed Web of Science ®Google Scholar
• Boraska JelavićTBarisićMDrmic HofmanIMicrosatelite GT polymorphism in the toll-like receptor 2 is associated with colorectal cancerClin Genet200670215616016879199
   PubMed Web of Science ®Google Scholar
• WangJHManningBJWuQDBlanksonSBouchier-HayesDRedmondHPEndotoxin/lipopolysaccharide activates NF-kappa B and enhances tumor cell adhesion and invasion through a beta 1 integrin-dependent mechanismJ Immunol2003170279580412517943
   PubMed Web of Science ®Google Scholar
• AndrewsEJWangJHWinterDCLaugWERedmondHPTumor cell adhesion to endothelial cells is increased by endotoxin via an upregulation of beta-1 integrin expressionJ Surg Res2001971141911319874
   PubMed Web of Science ®Google Scholar
• HsuRYChanCHSpicerJDLPS-induced TLR4 signaling in human colorectal cancer cells increases beta1 integrin-mediated cell adhesion and liver metastasisCancer Res20117151989199821363926
   PubMed Web of Science ®Google Scholar
• FriedmanSLMolecular regulation of hepatic fibrosis, an integrated cellular response to tissue injuryJ Biol Chem200027542247225010644669
   PubMed Web of Science ®Google Scholar
• TestroAGVisvanathanKToll-like receptors and their role in gastrointestinal diseaseJ Gastroenterol Hepatol200924694395419638078
   PubMed Web of Science ®Google Scholar
• WangJPZhangYWeiXCirculating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis CAPMIS2010118426127020402671
   PubMed Web of Science ®Google Scholar
• WeiXQGuoYWLiuJJWenZFYangSJYaoJLThe significance of Toll-like receptor 4 (TLR4) expression in patients with chronic hepatitis BClin Invest Med2008313E123E13018544275
   PubMed Web of Science ®Google Scholar
• MachidaKTsukamotoHMkrtchyanHToll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker NanogProc Natl Acad Sci U S A200910651548155319171902
   PubMed Web of Science ®Google Scholar
• NishimuraMNaitoSTissue-specific mRNA expression profiles of human toll-like receptors and related genesBiol Pharm Bull200528588689215863899
   PubMed Web of Science ®Google Scholar
• VonlaufenAXuZDanielBBacterial endotoxin: a trigger factor for alcoholic pancreatitis? Evidence from a novel, physiologically relevant animal modelGastroenterology200713341293130317919500
   PubMed Web of Science ®Google Scholar
• ZhangJJWuHSWangLTianYZhangJHWuHLExpression and significance of TLR4 and HIF-1alpha in pancreatic ductal adenocarcinomaWorld J Gastroenterol201016232881288820556833
   PubMed Web of Science ®Google Scholar
• MillerLSToll-like receptors in skinAdv Dermatol200824718719256306
   PubMedGoogle Scholar
• MolteniMMarabellaDOrlandiCRossettiCMelanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4Cancer Lett20062351758315922507
   PubMed Web of Science ®Google Scholar
• Sanchez-PerezLKottkeTDanielsGAKilling of normal melanocytes, combined with heat shock protein 70 and CD40L expression, cures large established melanomasJ Immunol200617764168417716951382
   PubMed Web of Science ®Google Scholar
• VoelckerVGebhardtCAverbeckMHyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4Exp Dermatol200817210010718031543
   PubMed Web of Science ®Google Scholar
• Saint-JeanMKnolACNguyenJMKhammariADrénoBTLR expression in human melanoma cellsEur J Dermatol201121689990521926036
   PubMed Web of Science ®Google Scholar
• WuJGuanMWongPFYuHDongJXuJIcariside II potentiates paclitaxel-induced apoptosis in human melanoma A375 cells by inhibiting TLR4 signaling pathwayFood Chem Toxicol20125093019302422743248
   PubMed Web of Science ®Google Scholar
• YusufNNastiTHLongJAProtective role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesisCancer Res200868261562218199559
   PubMed Web of Science ®Google Scholar
• ClarkeJHChaJYWalshMDMelanoma inhibits macrophage activation by suppressing toll-like receptor 4 signalingJ Am Coll Surg2005201341842516125076
   PubMed Web of Science ®Google Scholar
• XieWWangYHuangYYangHWangJHuZToll-like receptor 2 mediates invasion via activating NF-kappaB in MDA-MB-231 breast cancer cellsBiochem Biophys Res Commun200937941027103219141294
   PubMed Web of Science ®Google Scholar
• MerrellMAIlvesaroJMLehtonenNToll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activityMol Cancer Res20064743744716849519
   PubMed Web of Science ®Google Scholar
• YangHZhouHFengPReduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretionJ Exp Clin Cancer Res2010299220618976
   PubMed Web of Science ®Google Scholar
• HarmeyJHBucanaCDLuWLipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasionInt J Cancer2002101541542212216068
   PubMed Web of Science ®Google Scholar
• AhmedAWangJHRedmondHPSilencing of TLR4 increases tumor progression and lung metastasis in a murine model of breast cancerAnn Surg Oncol Epub2012814
   Web of Science ®Google Scholar
• EhsanNMuradSAshiqTSignificant correlation of TLR4 expression with the clinicopathological features of invasive ductal carcinoma of the breastTumour Biol20133421053105923338716
   PubMedGoogle Scholar
• González-ReyesSMarínLGonzálezLStudy of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasisBMC Cancer20101066521129170
   PubMed Web of Science ®Google Scholar
• LiaoSJZhouYHYuanYTriggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migrationBreast Cancer Res Treat2012133385386322042369
   PubMed Web of Science ®Google Scholar
• ApetohLTesniereAGhiringhelliFKroemerGZitvogelLMolecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapiesCancer Res200868114026403018519658
   PubMed Web of Science ®Google Scholar
• TheodoropoulosGESaridakisVKarantanosTToll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer developmentBreast201221453453822560646
   PubMed Web of Science ®Google Scholar
• EtokebeGEKnezevićJPetricevićBPavelićJVrbanecDDembićZSingle-nucleotide polymorphisms in genes encoding toll-like receptor -2, -3, -4, and -9 in case-control study with breast cancerGenet Test Mol Biomarkers200913672973419810822
   PubMed Web of Science ®Google Scholar
• SzajnikMSzczepanskiMJCzystowskaMTLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancerOncogene200928494353436319826413
   PubMed Web of Science ®Google Scholar
• KlinkMNowakMKielbikMThe interaction of HspA1A with TLR2 and TLR4 in the response of neutrophils induced by ovarian cancer cells in vitroCell Stress Chaperones201217666167422528050
   PubMed Web of Science ®Google Scholar
• WangACSuQBWuFXZhangXLLiuPSRole of TLR4 for paclitaxel chemotherapy in human epithelial ovarian cancer cellsEur J Clin Invest200939215716419200169
   PubMed Web of Science ®Google Scholar
• StanleyMAPettMRColemanNHPV: from infection to cancerBiochem Soc Trans200735Pt 61456146018031245
   PubMed Web of Science ®Google Scholar
• Platz-ChristensenJJSundströmELarssonPGBacterial vaginosis and cervical intraepithelial neoplasiaActa Obstet Gynecol Scand19947375865888079612
   PubMed Web of Science ®Google Scholar
• SmithJSBosettiCMuñozNIARC multicentric case-control studyChlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control studyInt J Cancer2004111343143915221973
   PubMed Web of Science ®Google Scholar
• WernerJDecarloCAEscottNZehbeIUlanovaMExpression of integrins and Toll-like receptors in cervical cancer: effect of infectious agentsInnate Immun2012181556921239458
   PubMed Web of Science ®Google Scholar
• YuLWangLLiMZhongJWangZChenSExpression of toll-like receptor 4 is down-regulated during progression of cervical neoplasiaCancer Immunol Immunother20105971021102820177675
   PubMed Web of Science ®Google Scholar
• HasanUABatesETakeshitaFTLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16J Immunol200717853186319717312167
   PubMed Web of Science ®Google Scholar
• PandeySMittalRDSrivastavaMImpact of Toll-like receptors [TLR] 2 (–196 to –174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian womenGynecol Oncol2009114350150519541348
   PubMed Web of Science ®Google Scholar
• GattiGRiveroVMotrichRDMaccioniMProstate epithelial cells can act as early sensors of infection by up-regulating TLR4 expression and proinflammatory mediators upon LPS stimulationJ Leukoc Biol200679598999816522744
   PubMed Web of Science ®Google Scholar
• González-ReyesSFernándezJMGonzálezLOStudy of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrenceCancer Immunol Immunother201160221722620978888
   PubMed Web of Science ®Google Scholar
• GattiGQuintarAAAndreaniVExpression of Toll-like receptor 4 in the prostate gland and its association with the severity of prostate cancerProstate200969131387139719496069
   PubMed Web of Science ®Google Scholar
• PeiZLinDSongXLiHYaoHTLR4 signaling promotes the expression of VEGF and TGFbeta1 in human prostate epithelial PC3 cells induced by lipopolysaccharideCell Immunol20082541202718649875
   PubMed Web of Science ®Google Scholar
• HuaDLiuMYChengZDSmall interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicityMol Immunol200946152876288419643479
   PubMed Web of Science ®Google Scholar
• VidasZPolymorphisms in Toll-like receptor genes – implications for prostate cancer developmentColl Antropol201034277978320698170
   PubMedGoogle Scholar
• ZhengSLAugustsson-BälterKChangBSequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden StudyCancer Res20046482918292215087412
   PubMed Web of Science ®Google Scholar
• SongJKimDYKimCSThe association between Toll-like receptor 4 (TLR4) polymorphisms and the risk of prostate cancer in Korean menCancer Genet Cytogenet20091902889219380025
   PubMedGoogle Scholar
• ChenYCGiovannucciELazarusRKraftPKetkarSHunterDJSequence variants of Toll-like receptor 4 and susceptibility to prostate cancerCancer Res20056524117711177816357190
   PubMed Web of Science ®Google Scholar
• ChengIPlummerSJCaseyGWitteJSToll-like receptor 4 genetic variation and advanced prostate cancer riskCancer Epidemiol Biomarkers Prev200716235235517301271
   PubMed Web of Science ®Google Scholar
• LindströmSHunterDJGrönbergHSequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studiesCancer Epidemiol Biomarkers Prev201019387387620200442
   PubMed Web of Science ®Google Scholar